EA201492153A1 - Смесь для ингибирования биосинтеза меланина - Google Patents

Смесь для ингибирования биосинтеза меланина

Info

Publication number
EA201492153A1
EA201492153A1 EA201492153A EA201492153A EA201492153A1 EA 201492153 A1 EA201492153 A1 EA 201492153A1 EA 201492153 A EA201492153 A EA 201492153A EA 201492153 A EA201492153 A EA 201492153A EA 201492153 A1 EA201492153 A1 EA 201492153A1
Authority
EA
Eurasian Patent Office
Prior art keywords
skin
mixture
melanin biosynthesis
counteract
cosmetic
Prior art date
Application number
EA201492153A
Other languages
English (en)
Other versions
EA030102B1 (ru
Inventor
Джанфранко Де Паоли Амбрози
Original Assignee
Дженераль Топикс С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженераль Топикс С.Р.Л. filed Critical Дженераль Топикс С.Р.Л.
Publication of EA201492153A1 publication Critical patent/EA201492153A1/ru
Publication of EA030102B1 publication Critical patent/EA030102B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к смеси, содержащей ацетилглюкозамин и 4-(1-фенилэтил)-1,3-бензолдиол, для применения в качестве косметического и/или лекарственного средства, и в частности для ингибирования биосинтеза меланина, и к косметической и/или фармацевтической композиции, содержащей такую смесь, для лечения гиперпигментированных поражений кожи, таких как, например, солнечное лентиго, возрастные пятна, мелазма и хлоазма, но не ограничивающихся ими, для придания однородного цвета коже, для противодействия образованию свободных радикалов и для противодействия или предупреждения признаков старения кожи, таких как морщины и утрата тона кожи, и для улучшения общего эстетического состояния кожи.
EA201492153A 2012-06-04 2013-06-04 Смесь для ингибирования биосинтеза меланина EA030102B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000092A ITBS20120092A1 (it) 2012-06-04 2012-06-04 Miscela per l'inibizione della biosintesi della melanina
PCT/IB2013/054606 WO2013182996A1 (en) 2012-06-04 2013-06-04 Mixture for the inhibition of melanin biosynthesis

Publications (2)

Publication Number Publication Date
EA201492153A1 true EA201492153A1 (ru) 2015-05-29
EA030102B1 EA030102B1 (ru) 2018-06-29

Family

ID=46758827

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492153A EA030102B1 (ru) 2012-06-04 2013-06-04 Смесь для ингибирования биосинтеза меланина

Country Status (14)

Country Link
US (1) US20150110725A1 (ru)
EP (1) EP2854783B1 (ru)
JP (1) JP2015518877A (ru)
KR (1) KR20150023544A (ru)
CN (1) CN104507462A (ru)
EA (1) EA030102B1 (ru)
ES (1) ES2668848T3 (ru)
IN (1) IN2014MN02468A (ru)
IT (1) ITBS20120092A1 (ru)
MY (1) MY169101A (ru)
PL (1) PL2854783T3 (ru)
SG (2) SG11201408053TA (ru)
TR (1) TR201806726T4 (ru)
WO (1) WO2013182996A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109789066A (zh) * 2016-06-30 2019-05-21 西姆莱斯股份公司 含有间苯二酚衍生物的药物和化妆组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002053448A (ja) * 2000-07-28 2002-02-19 Pentapharm Ltd アウトドア化粧料
DE10324566A1 (de) * 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
CN101365414A (zh) 2006-01-05 2009-02-11 西姆莱斯有限责任两合公司 包含酚类化合物和二苯甲酮的稳定化制剂
CN101139288B (zh) * 2006-09-07 2011-06-15 黑龙江大学 复合型固体超强酸催化制备亚油酸乙酯的方法
US20110171288A1 (en) * 2008-02-20 2011-07-14 Fatemeh Mohammadi Topical compositions and methods for whitening skin
FR2939669B1 (fr) * 2008-12-17 2011-03-25 Oreal Procede cosmetique pour controler le brunissement de la peau induit par les radiations uv ; compositions.
CA3043905A1 (en) * 2011-01-07 2012-07-12 Allergan, Inc. Compositions comprising substituted benzaldehydes and use thereof for lightening skin or treating hyperpigmenation and hypermelanosis disorders

Also Published As

Publication number Publication date
JP2015518877A (ja) 2015-07-06
PL2854783T3 (pl) 2018-08-31
IN2014MN02468A (ru) 2015-07-10
US20150110725A1 (en) 2015-04-23
SG11201408053TA (en) 2015-01-29
EP2854783B1 (en) 2018-02-14
MY169101A (en) 2019-02-18
EP2854783A1 (en) 2015-04-08
KR20150023544A (ko) 2015-03-05
ITBS20120092A1 (it) 2013-12-05
TR201806726T4 (tr) 2018-06-21
WO2013182996A1 (en) 2013-12-12
EA030102B1 (ru) 2018-06-29
CN104507462A (zh) 2015-04-08
SG10201704303VA (en) 2017-07-28
ES2668848T3 (es) 2018-05-22

Similar Documents

Publication Publication Date Title
CA2902938C (en) Peptides for skin rejuvenation and methods of using the same
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
PH12015500825B1 (en) Substituted benzene compounds
TNSN08381A1 (en) Cosmetic active ingredient composed of arginine ferrulate and a microalgae and extract its uses
MX344530B (es) Compuestos de benceno substituido.
WO2012037155A3 (en) Tyrosine kinase inhibitors
WO2012108689A3 (ko) 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도
PH12014501639A1 (en) Pharmaceutical compositions and methods
WO2012099449A3 (ko) 플라본계 화합물의 신규한 용도
WO2012108677A3 (ko) 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도
WO2012076109A3 (de) 2-pyrone
BR112013002215A2 (pt) uso de feijões de café verde para regulagem de distúrbios de pigmentação da pele
MX358727B (es) Composicion cosmetica dermatologica que comprende una merocianina y una fase aceitosa que comprende al menos un compuesto amido especifico.
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
WO2015081306A3 (en) Peptide tyrosinase activators
MX2014003449A (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
WO2009112653A3 (fr) Composition cosmétique et/ou dermatologique
MX2015009054A (es) Composicion cosmetica o dermatologica que comprende una merocianina, una fase aceitosa y un monoalcanol c1-c4.
EA201791493A1 (ru) Композиция для отбеливания кожи, содержащая ниацинамид и иломастат
EA201492153A1 (ru) Смесь для ингибирования биосинтеза меланина
TN2011000554A1 (en) Use of delta-tocopheryl-carbohydrate as a depigmenting agent
MX2009012712A (es) Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
EA201100392A1 (ru) Интерлейкин-1 бета в косметических композициях и способы его использования
WO2019078662A3 (ko) 데스모디움 스컥스 용매 추출물 또는 이의 분획물의 티로시나아제 저해 및 미백활성

Legal Events

Date Code Title Description
PC1A Registration of transfer to a eurasian application by force of assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM